Real Estate Fund

Investment Range

£10M - £50M

Performance Metrics

Target IRR

15–20%

Hold Period

5–10 years

Capital Deployment

£10M–£50M per project

Target Markets

UK, Western Europe and strategic Asian markets with a focus on urban regeneration zones and high-growth regions.

Investment Focus

Mixed-use urban developments, master-planned communities, commercial office repositioning and sustainable neighbourhood projects.

Value Creation

Master plan development participation, sustainable urban regeneration, smart city integration and community-focused value creation.

Infrastructure Fund

Investment Range

£10M–£100M

Performance Metrics

Target IRR

12–15%

Hold Period

7–15 years

Capital Deployment

£10M–£100M per project

Target Markets

Established markets in Europe and high-growth corridors in Southeast Asia with strong government support and regulatory frameworks.

Investment Focus

Economic corridor developments, smart city infrastructure, sustainable urban solutions and strategic regional developments.

Value Creation

Public-private partnerships, cross-border collaboration, sustainable development integration and long-term value creation through regional economic transformation.

Technology & Cyber Fund

Investment Range

£5M–£25M

Performance Metrics

Target IRR

25–30%

Hold Period

4–6 years

Capital Deployment

£5M–£25M per company

Target Markets

European tech hubs, UK innovation centres and Asian markets.

Investment Focus

Enterprise SaaS platforms, cybersecurity solutions, fintech innovations and cloud infrastructure services.

Value Creation

International market expansion, strategic acquisitions, product development acceleration and operational enhancement.

Healthcare Fund

Investment Range

£5M–£20M

Performance Metrics

Target IRR

20–25%

Hold Period

4–7 years

Capital Deployment

£5M–£20M per investment

Target Markets

UK, Europe and high-growth Asian healthcare markets.

Investment Focus

Digital health platforms, specialised care providers, healthcare technology solutions and diagnostic innovations.

Value Creation

Clinical excellence programmes, digital transformation initiatives, cross-border expansion and technological integration.

All funds operate under consistent principles

Investment Period

3-5 Years

Minimum Investment

£1M

Co-Investment Rights

Available for larger transactions

Special Purpose Vehicles

Available for significant development projects

Consortium Participation

Ability to participate in larger projects through strategic partnerships

Reporting

Quarterly portfolio updates

Exit Strategy

Multiple paths including strategic sales, IPOs and secondary transactions